Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Sci Rep ; 13(1): 10603, 2023 06 30.
Article in English | MEDLINE | ID: mdl-37391453

ABSTRACT

Distortion of dentition may occur in cone-beam computed tomography (CBCT) scans due to artifacts, and further imaging is frequently required to produce digital twins. The use of a plaster model is common; however, it has certain drawbacks. This study aimed to assess the feasibility of different digital dentition models over that of plaster casts. Plaster models, alginate impressions, intraoral scan (IOS) images, and CBCT images of 20 patients were obtained. The desktop model scanner was used to scan the alginate impression twice, five minutes and two hours after impression-making. Using an IOS, the full arch was scanned in segments using CS 3600 and simultaneously with i700 wireless. The digital twins obtained from the alginate impression and IOS were superimposed with those obtained from the plaster cast. The differences and distances at each reference point were measured. Scans of alginate impressions after two hours showed the greatest discrepancies, but these were all less than the CBCT voxel size of 0.39 mm. Alginate impression scans and IOS are suitable supplements to CBCT compared to the plaster model. Accuracy can be improved by scanning the alginate impression within five minutes or by intraoral scanning of the entire arch with segmentation.


Subject(s)
Cone-Beam Computed Tomography , Dentition , Humans , Alginates , Artifacts , Clonal Hematopoiesis
2.
J Gynecol Oncol ; 31(1): e10, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31789000

ABSTRACT

OBJECTIVES: Two randomized, controlled studies comparing outcomes in patients treated with direct oral anticoagulants or low-molecular weight heparin for cancer-associated venous thromboembolism (VTE) have previously been performed. However, gynecologic cancers accounted for approximately 10% of the study populations. We compared the outcomes of patients with primary gynecological cancers who were treated for cancer-associated VTE with either rivaroxaban or dalteparin. METHODS: The 162 eligible patients with gynecologic cancers who were treated with either dalteparin (n=60) or rivaroxaban (n=102) were reviewed. The primary outcome was a composite event, which included recurrence or clinically relevant bleeding events during the therapeutic period. Secondary outcomes were recurrence, clinically relevant bleeding events, and mortality. RESULTS: During the therapeutic period, there were no significant differences between the groups in the proportion of composite events, recurrence, or clinically relevant bleeding. Multivariate analysis using the Cox proportional hazards model also showed no significant difference in the number of composite events and clinically relevant bleeding between the groups. In the rivaroxaban group, 44.0% of patients experienced gastrointestinal bleeding and 24.0% experienced urinary tract bleeding. In the dalteparin group, bleeding was most common in the urinary tract (44.4%) and at the injection site (22.2%). CONCLUSION: In this study, although there were no significant differences in effectiveness or safety between the rivaroxaban and dalteparin groups, rivaroxaban use was associated with a higher rate of clinically relevant bleeding than dalteparin. Therefore, caution should be taken when prescribing rivaroxaban for gynecologic cancer-associated VTE and bleeding events should be carefully monitored.


Subject(s)
Dalteparin/adverse effects , Factor Xa Inhibitors/adverse effects , Rivaroxaban/adverse effects , Venous Thromboembolism/drug therapy , Aged , Dalteparin/administration & dosage , Factor Xa Inhibitors/administration & dosage , Female , Genital Neoplasms, Female/complications , Hemorrhage/chemically induced , Humans , Middle Aged , Proportional Hazards Models , Republic of Korea , Rivaroxaban/administration & dosage , Venous Thromboembolism/etiology
3.
PLoS One ; 14(5): e0217112, 2019.
Article in English | MEDLINE | ID: mdl-31120956

ABSTRACT

Ulmus macrocarpa Hance as an oriental medicinal plant has shown enormous potential for the treatment of several metabolic disorders in Korea. Hyperlipidemia, which is characterized by the excess accumulation of lipid contents in the bloodstream, may lead to several cardiovascular diseases. Therefore, in this study, anti-hyperlipidemic potential of U. macrocarpa water extract (UME) was examined in vitro and in vivo using HepG2 cells and experimental rats, respectively. The hyperlipidemia in experimental rats was induced by the high-cholesterol diet (HCD) followed by oral administration of various concentrations (25, 50 and 100 mg/kg) of UME for 6 weeks. As a result, the UME significantly improved the biochemical parameters such as increased the level of triglyceride, total cholesterol, and low-density lipoprotein cholesterol as well as reduced the high-density lipoprotein cholesterol in the HCD-fed rats. In addition, UME also prevented lipid accumulation through regulating AMPK activity and lipid metabolism proteins (ACC, SREBP1 and HMGCR) in the HCD-fed rats as compared to the controls. Moreover, similar pattern of gene expression levels was confirmed in oleic acid (OA)-treated HepG2 cells. Taken together, our results indicate that UME prevents hyperlipidemia via activating the AMPK pathway and regulates lipid metabolism. Thus, based on the above findings, it is estimated that UME could be a potential therapeutic agent for preventing the hyperlipidemia.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Diet, High-Fat/adverse effects , Gene Expression Regulation/drug effects , Hyperlipidemias/drug therapy , Lipid Metabolism/drug effects , Plant Extracts/pharmacology , Ulmus/chemistry , Animals , Hep G2 Cells , Humans , Hyperlipidemias/etiology , Hyperlipidemias/metabolism , Hyperlipidemias/pathology , Male , Rats , Rats, Sprague-Dawley
4.
Arch Oral Biol ; 96: 46-51, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30172945

ABSTRACT

OBJECTIVE: Remodeling of alveolar bone is controlled by osteoclast-mediated bone resorption and osteoblast-induced bone formation. LPS of Porphyromonas gingivalis, a major causative agent of periodontitis, produces proinflammatory cytokines in host immune cells, which thereby triggers osteoclastogenesis and leads to alveolar bone resorption. We investigated the anti-periodontitis potential of Platycarya strobilacea leaf extract (PLE), which is used as a traditional medicine in Asian countries. DESIGN: TNF-α levels in cell culture media were measured using a commercially available enzyme-linked immunosorbent assay kit. Osteoclast differentiation was observed by tartrate-resistant acid phosphatase staining, and the expression levels of osteoclastogenic genes were measured by quantitative real-time PCR. Bone-resorbing activity was confirmed by the resorption pit formation, gelatin zymographic, and the cathepsin K activity assays. Osteogenic differentiation was confirmed with an ALP activity assay and alizarin red S staining. RESULTS: PLE treatment inhibited the production of TNF-α in P. gingivalis LPS-stimulated RAW264.7 macrophages. In bone marrow-derived macrophages serving as osteoclast precursors, PLE treatment blocked RANKL-induced osteoclastogenesis and gene expression levels of the osteoclastogenic transcription factor NFATc1, DC-STAMP for osteoclast fusion, and cathepsin K for osteoclast activity. In addition, PLE treatment reduced the formation of resorption pits and the secretion of MMP 9 and cathepsin K from the differentiated osteoclasts. Furthermore, PLE treatment induced osteogenesis by increasing ALP activity and calcium content in preosteoblastic cells. CONCLUSION: PLE inhibits P. gingivalis LPS-induced TNF-α production and bone resorption and induces bone formation. PLE may be a beneficial agent to promote oral health by inhibiting periodontitis-induced alveolar bone loss.


Subject(s)
Alveolar Bone Loss/prevention & control , Juglandaceae/classification , Plant Extracts/pharmacology , Plant Leaves , Porphyromonas gingivalis/metabolism , Tumor Necrosis Factor-alpha/metabolism , Alveolar Bone Loss/microbiology , Animals , Cell Differentiation/drug effects , Enzyme-Linked Immunosorbent Assay , Lipopolysaccharides/pharmacology , Male , Mice , Osteoclasts/drug effects , Osteogenesis/drug effects , Real-Time Polymerase Chain Reaction
5.
JAMA Dermatol ; 153(7): 666-674, 2017 07 01.
Article in English | MEDLINE | ID: mdl-28355423

ABSTRACT

Importance: References to the expected treatment response to phototherapy would be helpful in the management of vitiligo because phototherapy requires long treatment durations over several months. Objective: To estimate the treatment response of vitiligo to phototherapy. Data Sources: A comprehensive database search of MEDLINE, EMBASE, and the Cochrane library from inception to January 26, 2016, was performed for all prospective studies. The main keywords used were vitiligo, phototherapy, psoralen, PUVA, ultraviolet, NBUVB, and narrowband. Study Selection: All prospective studies reporting phototherapy outcome for at least 10 participants with generalized vitiligo were included. Of 319 studies initially identified, the full texts of 141 studies were assessed for eligibility, and 35 were finally included in the analysis. Of these, 29 studies included 1201 patients undergoing narrowband UV-B (NBUVB) phototherapy, and 9 included 227 patients undergoing psoralen-UV-A (PUVA) phototherapy. Data Extraction and Synthesis: Two reviewers independently extracted the following data: study design, number and characteristics of the participants, phototherapy protocol, and rate of repigmentation based on the quartile scale. Single-arm meta-analyses were performed for the NBUVB and PUVA groups. Sample size-weighted means were calculated using a random-effects model for the repigmentation rates of the included studies. Main Outcomes and Measures: The primary outcomes were at least mild (≥25%), at least moderate (≥50%), and marked (≥75%) responses on a quartile scale. Response rates were calculated as the number of participants who showed the corresponding repigmentation divided by the number of all participants enrolled in the individual studies. Results: The meta-analysis included 35 unique studies (1428 unique patients). For NBUVB phototherapy, an at least mild response occurred in 62.1% (95% CI, 46.9%-77.3%) of 130 patients in 3 studies at 3 months, 74.2% (95% CI, 68.5%-79.8%) of 232 patients in 11 studies at 6 months, and 75.0% (95% CI, 60.9%-89.2%) of 512 patients in 8 studies at 12 months. A marked response was achieved in 13.0% (95% CI, 2.1%-23.9%) of 106 patients in 2 studies at 3 months, 19.2% (95% CI, 11.4%-27.0%) of 266 patients in 13 studies at 6 months, and 35.7% (95% CI, 21.5%-49.9%) of 540 patients in 9 studies at 12 months. For PUVA phototherapy, an at least mild response occurred in 51.4% (95% CI, 28.1%-74.7%) of 103 patients in 4 studies at 6 months and 61.6% (95% CI, 20.2%-100%) of 72 patients in 3 studies at 12 months. In the subgroup analyses, marked responses were achieved on the face and neck in 44.2% (95% CI, 24.2%-64.2%), on the trunk in 26.1% (95% CI, 8.7%-43.5%), on the extremities in 17.3% (95% CI, 8.2%-26.5%), and on the hands and feet in none after at least 6 months of NBUVB phototherapy. Conclusions and Relevance: Long-duration phototherapy should be encouraged to enhance the treatment response in vitiligo. The greatest response is anticipated on the face and neck.


Subject(s)
PUVA Therapy/methods , Phototherapy/methods , Vitiligo/therapy , Humans , Photosensitizing Agents/administration & dosage , Skin Pigmentation , Time Factors , Treatment Outcome , Ultraviolet Therapy/methods , Vitiligo/pathology
6.
J Am Acad Dermatol ; 74(5): 907-15, 2016 May.
Article in English | MEDLINE | ID: mdl-26785803

ABSTRACT

BACKGROUND: Combination therapies of excimer laser/light (EL) and various topical agents are widely used in the treatment of vitiligo. OBJECTIVE: We sought to compare the efficacy of EL and topical agent combination therapy versus EL monotherapy for vitiligo. METHODS: Manual searches of reference lists and computerized searches of the MEDLINE, EMBASE, and Cochrane library (from inception through December 15, 2014) were conducted to identify randomized controlled trials that assessed the efficacy of EL alone or in combination with topical agents for vitiligo. The primary outcome was treatment success (≥75% repigmentation), and the secondary outcome was treatment failure (<25% repigmentation); meta-analyses were performed when possible. RESULTS: We analyzed 8 randomized controlled trials comprising a total of 425 patches/patients. The combination of EL and topical calcineurin inhibitors (4 studies: relative risk 1.93, 95% confidence interval 1.28-2.91; number needed to treat 4.5, 95% confidence interval 2.9-10) was superior to EL monotherapy for vitiligo. There was insufficient evidence to support beneficial effects of topical vitamin-D3 analogs (3 studies) and corticosteroids (1 study). LIMITATIONS: These findings are based on small numbers of randomized controlled trials and heterogeneities among included studies are another limitation. CONCLUSION: Topical calcineurin inhibitors in conjunction with EL are more effective compared with EL monotherapy.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Calcineurin Inhibitors/therapeutic use , Lasers, Excimer/therapeutic use , Phototherapy/methods , Vitiligo/diagnosis , Vitiligo/therapy , Administration, Topical , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Male , Randomized Controlled Trials as Topic , Risk Assessment , Severity of Illness Index , Treatment Outcome
8.
Chem Biodivers ; 12(3): 380-7, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25766911

ABSTRACT

Coicis semen (=the hulled seed of Coix lacryma-jobi L. var. ma-yuen (Rom.Caill.) Stapf; Gramineae), commonly known as adlay and Job's tears, is widely used in traditional medicine and as a nutritious food. Bioassay-guided fractionation of the AcOEt fraction of unhulled adlays, using measurement of nitric oxide (NO) production on lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells, led to the isolation and identification of two new stereoisomers, (+)-(7'S,8'R,7″S,8″R)-guaiacylglycerol ß-O-4'-dihydrodisinapyl ether (1) and (+)-(7'S,8'R,7″R,8″R)-guaiacylglycerol ß-O-4'-dihydrodisinapyl ether (2), together with six known compounds, 3-8. Compounds 3 and 4 exhibited inhibitory activities on LPS-induced NO production with IC50 values of 1.4 and 3.7 µM, respectively, and suppressed inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) protein expressions in RAW 264.7 macrophage cells. Simple high-performance liquid chromatography with ultraviolet detection (HPLC/UV) was used to compare the AcOEt fraction of unhulled adlays responsible for the anti-inflammatory activity in RAW 264.7 cells and the inactive AcOEt fraction of hulled adlays.


Subject(s)
Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Coix/chemistry , Lipopolysaccharides/immunology , Macrophages/drug effects , Plant Extracts/chemistry , Plant Extracts/pharmacology , Animals , Anti-Inflammatory Agents/isolation & purification , Cell Line , Cyclooxygenase 2 Inhibitors/chemistry , Cyclooxygenase 2 Inhibitors/isolation & purification , Cyclooxygenase 2 Inhibitors/pharmacology , Macrophages/immunology , Mice , Nitric Oxide/immunology , Nitric Oxide Synthase Type II/antagonists & inhibitors , Nitric Oxide Synthase Type II/immunology , Plant Extracts/isolation & purification
9.
Int J Oral Maxillofac Implants ; 27(2): 265-72, 2012.
Article in English | MEDLINE | ID: mdl-22442763

ABSTRACT

PURPOSE: Although the laser has become one of the most commonly used tools for implant dentistry, research is lacking on whether or not the laser causes any changes on the surface of titanium (Ti) implants. The present study analyzed the morphology, composition, crystal structure, and surface roughness changes of machined and anodized Ti surfaces, irradiated with erbium chromium-doped yttrium-scandium-gallium-garnet (Er,Cr:YSGG), erbium-doped yttrium-aluminum-garnet (Er:YAG), and carbon dioxide (CO2) lasers. MATERIALS AND METHODS: Seventy-two Ti disks were fabricated by machining commercially pure Ti (grade 3); 36 of them were anodized at 300 V. The disks were irradiated with Er,Cr:YSGG, Er:YAG, and CO2 lasers at five different powers (1, 2, 3, 4, and 5 W). The irradiated disks were examined with scanning electron microscopy, electron probe microanalysis, x-ray diffractometry, and optical interferometry. RESULTS: Surface changes were observed on both types of Ti surfaces irradiated with the Er,Cr:YSGG laser when more than 3 W of power were applied. Surface changes were observed on both types of Ti surfaces when irradiated with the Er:YAG laser with more than 2 W of power. No change was observed when the disks were irradiated with the CO2 laser. The proportion of oxide in the machined Ti disk increased after the application of the Er,Cr:YSGG or Er:YAG laser. In the anodized Ti disk, the anatase peak intensity decreased and the rutile peak intensity increased after laser irradiation. The irradiated Ti disks were significantly rougher than the nonirradiated Ti disks. CONCLUSIONS: The Er:YAG and Er,Cr:YSGG laser resulted in surface changes on the Ti disks according to the power output. The CO2 laser did not affect the surface of the Ti disks, irrespective of the power output.


Subject(s)
Dental Materials/radiation effects , Lasers, Gas , Lasers, Solid-State , Titanium/radiation effects , Calcium/analysis , Carbon/analysis , Crystallography , Dental Materials/chemistry , Electrochemical Techniques , Electron Probe Microanalysis , Humans , Interferometry , Light , Materials Testing , Microscopy, Electron, Scanning , Nitrogen/analysis , Oxidation-Reduction , Oxygen/analysis , Phosphorus/analysis , Radiation Dosage , Surface Properties , Time Factors , Titanium/analysis , Titanium/chemistry , X-Ray Diffraction
10.
Biotechnol Bioeng ; 94(6): 1025-32, 2006 Aug 20.
Article in English | MEDLINE | ID: mdl-16547999

ABSTRACT

To increase expression of lycopene synthetic genes crtE, crtB, crtI, and ipiHP1, the four exogenous genes were cloned into a high copy pTrc99A vector with a strong trc promoter. Recombinant Escherichia coli harboring pT-LYCm4 produced 17 mg/L of lycopene. The mevalonate lower pathway, composed of mvaK1, mvaK2, mvaD, and idi, was engineered to produce pSSN12Didi for an efficient supply of the lycopene building blocks, isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). Mevalonate was supplied as a substrate for the mevalonate lower pathway. Lycopene production in E. coli harboring pT-LYCm4 and pSSN12Didi with supplementation of 3.3 mM mevalonate was more than threefold greater than bacteria with pT-LYCm4 only. Lycopene production was dependent on mevalonate concentration supplied in the culture. Clump formation was observed as cells accumulated more lycopene. Further clumping was prevented by adding the surfactant Tween 80 0.5% (w/v), which also increased lycopene production and cell growth. When recombinant E. coli harboring pT-LYCm4 and pSSN12Didi was cultivated in 2YT medium containing 2% (w/v) glycerol as a carbon source, 6.6 mM mevalonate for the mevalonate lower pathway, and 0.5% (w/v) Tween 80 to prevent clump formation, lycopene production was 102 mg/L and 22 mg/g dry cell weight, and cell growth had an OD(600) value of 15 for 72 h.


Subject(s)
Carotenoids/biosynthesis , Cell Culture Techniques/methods , Escherichia coli/metabolism , Genetic Enhancement/methods , Hemiterpenes/biosynthesis , Mevalonic Acid/metabolism , Organophosphorus Compounds/metabolism , Cloning, Molecular , Escherichia coli/genetics , Lycopene , Protein Engineering/methods , Recombinant Proteins/metabolism
11.
Plant Physiol Biochem ; 43(4): 397-406, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15907692

ABSTRACT

Here we characterized a rice (Oryza sativa L.) blast lesion mimic (blm) mutant, identified previously in an N-methyl-N-nitrosourea-mutagenized population of the cultivar Hwacheong (wild type). The rice blm displayed spontaneous necrotic lesion formation on the leaves during development under long-day condition and temperature shift from 28 to 24 degrees C in the absence of obvious stress/disease, and provided us with a highly reproducible and convenient experimental system in the growth chamber to study blm. The blm phenotype resembled to the cell death of hypersensitive reaction (HR), and subsequent, two-dimensional gel electrophoresis (2-DGE) revealed induction of many leaf proteins; prominent among them were the three pathogenesis-related (PR) marker proteins of class 5 (one spot) and 10 (two spots). Interestingly, the rice blm manifested HR against all races tested of the rice blast fungus (Magnaporthe grisea), providing high resistance in a non-race specific manner. It was also observed that blm was highly resistant to hydrogen peroxide treatment. Using 2-DGE immunoblotting, we identified the presence of 4 new spots cross-reacting with a superoxide dismutase (SOD) antibody, only in blm, suggesting the expression of potentially new SOD protein (isoforms) during lesion formation. In the leaves of blm, autofluorescent compounds accumulated in and around the site of lesion progression. Moreover, enhanced levels of two major rice phytoalexins, sakuranetin and momilactone A were also observed in the leaves of blm. These results indicate that blm confers broad-spectrum resistance to multiple pathogens, and so, it could be hypothesized that the BLM gene product may control the HR-like cell death and its associated multiple defense signaling pathways, as evidenced by induction of known hallmark features (proteins/metabolites) linked with the defense responses, in rice.


Subject(s)
Magnaporthe/pathogenicity , Oryza/genetics , Oryza/microbiology , Antifungal Agents/metabolism , Diterpenes/metabolism , Flavonoids/metabolism , Hydrogen Peroxide/pharmacology , Mutation , Oryza/metabolism , Oxidative Stress , Phenols/metabolism , Plant Diseases/genetics , Plant Diseases/microbiology , Plant Extracts/metabolism , Plant Proteins/genetics , Plant Proteins/isolation & purification , Plant Proteins/metabolism , Sesquiterpenes , Signal Transduction , Superoxide Dismutase/genetics , Superoxide Dismutase/isolation & purification , Superoxide Dismutase/metabolism , Terpenes , Phytoalexins
12.
J Biochem Mol Biol ; 36(3): 258-64, 2003 May 31.
Article in English | MEDLINE | ID: mdl-12787479

ABSTRACT

This study examined the effect of dietary polyunsaturated fatty acids (PUFA) that were supplemented with vitamin E on lipid peroxidation, glutathione-dependent detoxifying enzyme system activity, and lipogenic fatty acid synthase (FAS) expression in rat liver. Male Sprague-Dawley rats were fed semipurified diets containing either 1% (w/w) corn oil or 10% each of beef tallow, corn oil, perilla oil, and fish oil for 4 wk. Alpha-tocopherol was supplemented in perilla oil (0.015%) and fish oil (0.019%). Hepatic thiobarbituric acid reactive substances, an estimate of lipid peroxidation, were not significantly different among the dietary groups. The glutathione peroxidase, glutathione reductase, and glutathione S-transferase activities were all elevated by the polyunsaturated fats, especially fish oil. The activity of FAS was reduced in the polyunsaturated fat-fed groups in the order of fish oil, perilla oil, and corn oil. The mRNA contents decreased in rats that were fed the 10% fat diets, particularly polyunsaturated fats, compared with the rats that were fed the 1% corn oil diet. Similarly, the inhibitory effect was the greatest in fish oil. These results suggest that lipid peroxidation can be minimized by vitamin E; PUFA in itself has a suppressive effect on lipogenic enzyme.


Subject(s)
Dietary Fats, Unsaturated/administration & dosage , Fatty Acid Synthases/antagonists & inhibitors , Lipid Peroxides/metabolism , Animals , Blotting, Northern , Corn Oil/administration & dosage , Enzyme Activation/drug effects , Fats/administration & dosage , Fatty Acid Synthases/genetics , Fatty Acid Synthases/metabolism , Fatty Acids/analysis , Fish Oils/administration & dosage , Gene Expression Regulation, Enzymologic/drug effects , Glutathione Peroxidase/metabolism , Glutathione Reductase/metabolism , Glutathione Transferase/metabolism , Lipid Metabolism , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/enzymology , Male , Plant Oils/administration & dosage , RNA, Messenger/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , alpha-Linolenic Acid/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL